Brian Burchell

15.1k total citations · 2 hit papers
227 papers, 12.6k citations indexed

About

Brian Burchell is a scholar working on Pharmacology, Molecular Biology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Brian Burchell has authored 227 papers receiving a total of 12.6k indexed citations (citations by other indexed papers that have themselves been cited), including 113 papers in Pharmacology, 99 papers in Molecular Biology and 61 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Brian Burchell's work include Pharmacogenetics and Drug Metabolism (109 papers), Neonatal Health and Biochemistry (54 papers) and Drug Transport and Resistance Mechanisms (40 papers). Brian Burchell is often cited by papers focused on Pharmacogenetics and Drug Metabolism (109 papers), Neonatal Health and Biochemistry (54 papers) and Drug Transport and Resistance Mechanisms (40 papers). Brian Burchell collaborates with scholars based in United Kingdom, United States and France. Brian Burchell's co-authors include Robert Hume, Michael W.H. Coughtrie, Douglas J. Clarke, Thomas Ebner, Thomas R. Tephly, Gabriele Jedlitschky, Sylvie Fournel‐Gigleux, Gemma Monaghan, Karl Walter Bock and Dietrich Keppler and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Brian Burchell

227 papers receiving 12.1k citations

Hit Papers

The UDP glycosyltransferase gene superfamily: recommended... 1997 2026 2006 2016 1997 2005 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The UDP glycosyltransferase gene superfamily: recommended nomenclature update based on evolutionary divergence
    1997 985 citations Peter I. Mackenzie, Brian Burchell et al. Pharmacogenetics profile →
  2. Nomenclature update for the mammalian UDP glycosyltransferase (UGT) gene superfamily
    2005 653 citations Peter I. Mackenzie, Brian Burchell et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brian Burchell United Kingdom 62 5.6k 5.4k 3.3k 3.2k 1.1k 227 12.6k
Thomas R. Tephly United States 54 4.2k 0.8× 4.2k 0.8× 1.9k 0.6× 2.3k 0.7× 572 0.5× 175 10.4k
Tsuyoshi Yokoi Japan 67 6.2k 1.1× 7.2k 1.3× 1.7k 0.5× 4.8k 1.5× 875 0.8× 369 16.2k
Robert H. Tukey United States 52 3.9k 0.7× 4.5k 0.8× 1.7k 0.5× 2.5k 0.8× 534 0.5× 166 9.6k
Tetsuya Kamataki Japan 56 5.5k 1.0× 7.9k 1.5× 892 0.3× 4.0k 1.2× 341 0.3× 364 13.7k
Dominique Pessayre France 69 4.2k 0.8× 5.0k 0.9× 697 0.2× 2.1k 0.6× 932 0.9× 248 14.6k
Erin G. Schuetz United States 77 4.7k 0.9× 9.8k 1.8× 4.0k 1.2× 9.7k 3.0× 1.6k 1.5× 198 19.9k
Miki Nakajima Japan 60 4.5k 0.8× 4.7k 0.9× 1.1k 0.3× 3.0k 0.9× 480 0.4× 267 11.0k
Thomas K. H. Chang United States 59 3.9k 0.7× 6.4k 1.2× 1.0k 0.3× 3.0k 0.9× 278 0.3× 222 12.1k
Philip S. Guzelian United States 56 2.4k 0.4× 5.9k 1.1× 930 0.3× 3.5k 1.1× 900 0.8× 120 10.1k
Hiroyuki Kusuhara Japan 75 3.2k 0.6× 3.5k 0.6× 5.9k 1.8× 10.6k 3.3× 1.4k 1.3× 322 15.7k

Countries citing papers authored by Brian Burchell

Since Specialization
Citations

This map shows the geographic impact of Brian Burchell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian Burchell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian Burchell more than expected).

Fields of papers citing papers by Brian Burchell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian Burchell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian Burchell. The network helps show where Brian Burchell may publish in the future.

Co-authorship network of co-authors of Brian Burchell

This figure shows the co-authorship network connecting the top 25 collaborators of Brian Burchell. A scholar is included among the top collaborators of Brian Burchell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian Burchell. Brian Burchell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lewis, Benjamin C., Peter I. Mackenzie, David J. Elliot, et al.. (2006). Amino terminal domains of human UDP-glucuronosyltransferases (UGT) 2B7 and 2B15 associated with substrate selectivity and autoactivation. Biochemical Pharmacology. 73(9). 1463–1473. 41 indexed citations
2.
Cummings, Jeffrey L., Brian Ethell, Lesley Jardine, & Brian Burchell. (2006). Glucuronidation of SN-38 and NU/ICRF 505 in human colon cancer and adjacent normal colon.. PubMed. 26(3B). 2189–96. 11 indexed citations
3.
Balcerczyk, Aneta, Błażej Rychlik, Marcin Kruszewski, Brian Burchell, & Grzegorz Bartosz. (2003). MRP1-Transfected Cells do not Show Increased Resistance Against Oxidative Stress. Free Radical Research. 37(2). 189–195. 10 indexed citations
4.
Cummings, Jeffrey L., Brian Ethell, Lesley Jardine, et al.. (2003). Glucuronidation as a mechanism of intrinsic drug resistance in human colon cancer: reversal of resistance by food additives.. PubMed. 63(23). 8443–50. 70 indexed citations
5.
Rychlik, Błażej, et al.. (2001). Characterisation of glucuronidation and transport in V79 cells co-expressing UGT1A1 and MRP1. Toxicology Letters. 120(1-3). 43–49. 7 indexed citations
6.
Soars, Matthew G., et al.. (2001). Evaluation of the marmoset as a model species for drug glucuronidation. Xenobiotica. 31(12). 849–860. 22 indexed citations
7.
Jedlitschky, Gabriele, Brian Burchell, & Dietrich Keppler. (2000). The Multidrug Resistance Protein 5 Functions as an ATP-dependent Export Pump for Cyclic Nucleotides. Journal of Biological Chemistry. 275(39). 30069–30074. 364 indexed citations
8.
9.
Burchell, Brian, et al.. (2000). Drug-mediated toxicity caused by genetic deficiency of UDP-glucuronosyltransferases. Toxicology Letters. 112-113. 333–340. 67 indexed citations
10.
Jedlitschky, Gabriele, Andrew Cassidy, Mark Sales, Norman Pratt, & Brian Burchell. (1999). Cloning and characterization of a novel human olfactory UDP-glucuronosyltransferase. Biochemical Journal. 340(3). 837–837. 22 indexed citations
11.
12.
Burchell, Brian & Michael W.H. Coughtrie. (1997). Genetic and environmental factors associated with variation of human xenobiotic glucuronidation and sulfation.. Environmental Health Perspectives. 105(suppl 4). 739–747. 69 indexed citations
13.
Miners, John O., Luísa M.P. Valente, K.J. Lillywhite, et al.. (1997). Preclinical prediction of factors influencing the elimination of 5,6-dimethylxanthenone-4-acetic acid, a new anticancer drug.. PubMed. 57(2). 284–9. 58 indexed citations
14.
Monaghan, Gemma, Brian Foster, Mallé Jurima‐Romet, Robert Hume, & Brian Burchell. (1997). UGT1*1 genotyping in a Canadian Inuit population. Pharmacogenetics. 7(2). 153–156. 39 indexed citations
15.
Ding, Shaohong, et al.. (1996). Coexpression of a human P450 (CYP3A4) and P450 reductase generates a highly functional monooxygenase system in Escherichia coli. FEBS Letters. 397(2-3). 210–214. 81 indexed citations
16.
Sutherland, Lesley, Thomas Ebner, & Brian Burchell. (1993). The expression of UDP-glucuronosyltransferases of the UGT1 family in human liver and kidney and in response to drugs. Biochemical Pharmacology. 45(2). 295–301. 86 indexed citations
17.
Miles, John S., Julie Moss, Benjamin A. Taylor, Brian Burchell, & C. Roland Wolf. (1991). Mapping genes encoding drug-metabolizing enzymes in recombinant inbred mice. Genomics. 11(2). 309–316. 24 indexed citations
18.
Fournel‐Gigleux, Sylvie, et al.. (1989). Novel inhibitors and substrates of bilirubin: UDP‐glucuronosyltransferase Arylalkylcarboxylic acids. European Journal of Biochemistry. 183(3). 653–659. 25 indexed citations
19.
Harding, David, et al.. (1989). Phenol UDP-glucuronosyltransferase deficiency in Gunn rats: mRNA levels are considerably reduced. Biochemical Pharmacology. 38(6). 1013–1017. 7 indexed citations
20.
Burchell, Brian, Jacques Magdalou, & Gérard Siest. (1988). Cellular and molecular aspects of glucuronidation = Aspects cellulaires et moléculaires de la glucuronoconjugaison. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Thomas R. Tephly Breakdown of academic impact, for papers by Tsuyoshi Yokoi Breakdown of academic impact, for papers by Robert H. Tukey Breakdown of academic impact, for papers by Tetsuya Kamataki Breakdown of academic impact, for papers by Dominique Pessayre Breakdown of academic impact, for papers by Erin G. Schuetz Breakdown of academic impact, for papers by Miki Nakajima Breakdown of academic impact, for papers by Thomas K. H. Chang Breakdown of academic impact, for papers by Philip S. Guzelian Breakdown of academic impact, for papers by Hiroyuki Kusuhara
Rankless by CCL
2026